Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/3/2025 | $56.00 | Market Perform | BMO Capital Markets |
| 8/25/2025 | $65.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 4/7/2025 | $56.00 → $33.00 | Equal-Weight → Underweight | Morgan Stanley |
| 1/3/2025 | Outperform → Peer Perform | Wolfe Research | |
| 12/20/2024 | $65.00 → $57.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/9/2024 | $60.00 → $63.00 | Overweight → Equal-Weight | Morgan Stanley |
| 9/12/2024 | $51.00 | Equal Weight | Wells Fargo |
| 1/29/2024 | $51.00 | Outperform | Keefe Bruyette |
Lazard, Inc. (NYSE:LAZ) reported today that its preliminary assets under management ("AUM") as of September 30, 2025 totaled approximately $264.5 billion. The month's AUM included market appreciation of $5.4 billion, FX appreciation of $0.5 billion, and net inflows of $0.3 billion. Preliminary average AUM for the quarter ended September 30, 2025 was $257.4 billion. LAZARD, INC. ASSETS UNDER MANAGEMENT ("AUM") (unaudited) ($ in millions) As of: September 30, August 31, 20251 2025 Equity $208,510 $202,509 Fixed Income 47,186 46,8
Lazard, Inc. (NYSE:LAZ) will announce its third quarter and nine month 2025 financial results in a press release to be issued Thursday morning, October 23, 2025. The press release will be available in the News & Announcements section of Lazard's website at www.lazard.com. Lazard will host a conference call at 8:00 a.m. ET on October 23, 2025, to discuss the company's financial results. The conference call can be accessed via a live audio webcast available through the Investor Relations section of Lazard's website at www.lazard.com, or by dialing 1 800-445-7795 (toll-free within the U.S. and Canada) or +1 785-424-1699 (outside of the U.S. and Canada) 15 minutes prior to the start of the ca
ETF Brings Lazard's Decades of Infrastructure Expertise to Investors in a Transparent, Efficient Format Lazard Asset Management ("LAM") today announced the launch of the Lazard Listed Infrastructure ETF (NYSE:GLIX), a high-conviction, actively managed equity strategy designed to provide investors access to Lazard's expertise in investing in listed infrastructure companies. The launch of GLIX represents another cornerstone in Lazard's mission to offer compelling investment solutions that enable investors to pursue their most important long-term goals. "At Lazard, we believe infrastructure is at the epicenter of the modern economy and provides a compelling investment opportunity," said Ro
144 - Lazard, Inc. (0001311370) (Subject)
8-K - Lazard, Inc. (0001311370) (Filer)
8-K - Lazard, Inc. (0001311370) (Filer)
BMO Capital Markets initiated coverage of Lazard with a rating of Market Perform and set a new price target of $56.00
Keefe Bruyette upgraded Lazard from Mkt Perform to Outperform and set a new price target of $65.00
Morgan Stanley downgraded Lazard from Equal-Weight to Underweight and set a new price target of $33.00 from $56.00 previously
4 - Lazard, Inc. (0001311370) (Issuer)
4 - Lazard, Inc. (0001311370) (Issuer)
4 - Lazard, Inc. (0001311370) (Issuer)
Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio
Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an
Succeeds Evan Russo who transitions into advisory role following two decades of leadership at the firm Lazard, Inc. (NYSE:LAZ) today announced Christopher Hogbin has been appointed CEO of Lazard Asset Management, effective December 2025. Mr. Hogbin has 30 years of professional experience, including 20 years at AllianceBernstein where he most recently served as Global Head of Investments and a member of its Executive Leadership Team. An accomplished global business and investment leader, Mr. Hogbin played a pivotal role in expanding and diversifying AllianceBernstein's investment capabilities across public and private markets, elevating its research function, and delivering exceptional out
Lazard, Inc. (NYSE:LAZ) will announce its third quarter and nine month 2025 financial results in a press release to be issued Thursday morning, October 23, 2025. The press release will be available in the News & Announcements section of Lazard's website at www.lazard.com. Lazard will host a conference call at 8:00 a.m. ET on October 23, 2025, to discuss the company's financial results. The conference call can be accessed via a live audio webcast available through the Investor Relations section of Lazard's website at www.lazard.com, or by dialing 1 800-445-7795 (toll-free within the U.S. and Canada) or +1 785-424-1699 (outside of the U.S. and Canada) 15 minutes prior to the start of the ca
Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on October 22, 2025, to shareholders of record on October 10, 2025. The ex-dividend date is October 10, 2025. The Fund will pay a previously declared distribution today, September 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,
Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on September 22, 2025, to shareholders of record on September 11, 2025. The ex-dividend date is September 11, 2025. The Fund will pay a previously declared distribution today, August 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment incom
SC 13G - Lazard, Inc. (0001311370) (Subject)
SC 13G/A - Lazard, Inc. (0001311370) (Subject)
SC 13G/A - Lazard, Inc. (0001311370) (Subject)